TG Therapeutics (NASDAQ:TGTX) Trading 7.6% Higher

TG Therapeutics, Inc. (NASDAQ:TGTX – Get Rating)’s share price traded up 7.6% during mid-day trading on Monday . The stock traded as high as $16.22 and last traded at $16.19. 1,867,523 shares changed hands during mid-day trading, a decline of 57% from the average session volume of 4,388,624 shares. The stock had previously closed at […]

Related Keywords

Yann Echelard ,Michael Sean Weiss ,Laurenceh Shaw ,Deerfield Management Companylp Series ,Nasdaq ,Tg Therapeutics Inc ,Blackrock Inc ,Alkeon Capital Management ,Cantor Fitzgerald ,Securities Exchange Commission ,Vanguard Group Inc ,Get Rating ,Stock Down ,Director Yann Echelard ,Exchange Commission ,Street Corp ,Capital Management ,Tg Therapeutics ,Nasdaq Tgtx ,Tgtx ,Medical ,Stocks ,Technicals ,